Literature DB >> 1997186

Expression of cathepsin L in human tumors.

S S Chauhan1, L J Goldstein, M M Gottesman.   

Abstract

It has been proposed that proteases secreted by cancer cells facilitate tumor invasion and metastasis by degrading the components of extracellular membranes. The lysosomal cysteine protease cathepsin L is synthesized in large amounts and secreted by many malignantly transformed cells in culture. The secreted protease is potent in degrading collagen, laminin, elastin, and other structural proteins of basement membranes. To determine whether human cancers synthesize cathepsin L, the expression of cathepsin L in approximately 100 human tumor samples was determined by quantitative RNA slot blot analysis using a specific human cathepsin L complementary DNA probe. Results of the present study suggest that cancers in general express higher levels of cathepsin L than do normal tissues. Kidney and testicular tumors expressed the highest levels of cathepsin L; non-small cell carcinomas of the lung expressed the next highest levels; and most cancers of the breast, ovary, colon, adrenal, bladder, prostate, and thyroid expressed elevated levels as well. Cathepsin L may prove useful as a diagnostic or prognostic marker of human malignancy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997186

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice.

Authors:  Fusanori Nishimura; Hisa Naruishi; Koji Naruishi; Teruo Yamada; Junzo Sasaki; Christoph Peters; Yasuo Uchiyama; Yoji Murayama
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

Review 3.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

4.  Selective in vivo metabolic cell-labeling-mediated cancer targeting.

Authors:  Hua Wang; Ruibo Wang; Kaimin Cai; Hua He; Yang Liu; Jonathan Yen; Zhiyu Wang; Ming Xu; Yiwen Sun; Xin Zhou; Qian Yin; Li Tang; Iwona T Dobrucki; Lawrence W Dobrucki; Eric J Chaney; Stephen A Boppart; Timothy M Fan; Stéphane Lezmi; Xuesi Chen; Lichen Yin; Jianjun Cheng
Journal:  Nat Chem Biol       Date:  2017-02-13       Impact factor: 15.040

5.  Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics.

Authors:  Young Ah Goo; Alvin Y Liu; Soyoung Ryu; Scott A Shaffer; Lars Malmström; Laura Page; Liem T Nguyen; Catalin E Doneanu; David R Goodlett
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

6.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.

Authors:  Dhivya R Sudhan; Maria B Rabaglino; Charles E Wood; Dietmar W Siemann
Journal:  Clin Exp Metastasis       Date:  2016-04-07       Impact factor: 5.150

8.  The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.

Authors:  P K Lipponen
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.

Authors:  Nathalie Guillaume-Rousselet; Didier Jean; Raymond Frade
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

10.  Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.

Authors:  Inigo Espinosa; Andrew H Beck; Cheng-Han Lee; Shirley Zhu; Kelli D Montgomery; Robert J Marinelli; Kristen N Ganjoo; Torsten O Nielsen; C Blake Gilks; Robert B West; Matt van de Rijn
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.